rs141211612

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP4_ModeratePP3PP1

This summary comes from the ClinGen Evidence Repository: NM_000552.5(VWF):c.4130C>T is a missense variant in VWF that replaces alanine with valine at position 1377. At least 1 patient with this variant, in combination with p.Arg1379Cys (ClinVar 100333; Pathogenic VWD type 1) in cis, displayed excessive mucocutaneous bleeding as well as laboratory phenotypes of a normal multimer pattern, low VWF:RCo/VWF:Ag ratio (0.6 to 0.7), and decreased GP1b binding assay which together are highly specific for VWD type 2M (PP4_moderate, PMID:27785872). The p.Ala1377Val and p.Arg1379Cys variants have been reported in cis in 3 additional probands with high mucocutaneous bleeding as well as laboratory phenotypes of a normal multimer pattern, low VWF:RCo/VWF:Ag ratio (0.6 to 0.7), and decreased GP1b binding assay, but the four patients from Milan show the same short tandem repeats nearby, indicating the possibility of a common ancestor. The proband of Family VIII (PMID:35452508) has 3 additional type 2M diagnosed individuals, 2 are counted here with VWF Act/ VWF:Ag ratio <=0.42 (the other is 0.75). Each individual is heterozygous for p.A1377V; p.R1379C (PP1). The Grpmax filtering allele frequency of this variant in gnomAD v4.1 is 0.001967 (based on 170/75034 alleles in the African / African-American population), which is lower than the ClinGen VWD VCEP threshold for BS1 (>0.01) and higher than the threshold for PM2_Supporting (<0.0001). GP1b-alpha binding assay performed with recombinant VWF expressed by HEK-293 cells showed severely decreased binding when p.Ala1377Val was combined with the p.Arg1379Cys variant, indicating that the combination of these two variants has a damaging effect on protein function. PS3_Supporting was not met because the individual p.Ala1377Val and p.Arg1379Arg mutants showed approximately wild-type binding to GpIb-alpha (PMID:27785872). The computational predictor REVEL gives a score of 0.805, which is above the ClinGen VWD VCEP threshold of >0.644 and predicts a damaging effect on VWF function (PP3). In summary, this variant meets the criteria to be classified as a variant of unknown significance for hereditary von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: PP4_Moderate, PP3, PP1. (Rule specifications for von Willebrand disease type 2A, 2B and 2M v1.0.0; date of approval 08/12/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA6402597/MONDO:0019565/090

Frequency

Genomes: 𝑓 0.00060 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000072 ( 0 hom. )

Consequence

VWF
NM_000552.5 missense

Scores

10
5
3

Clinical Significance

Uncertain significance reviewed by expert panel U:7

Conservation

PhyloP100: 9.22

Publications

8 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000552.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VWF
NM_000552.5
MANE Select
c.4130C>Tp.Ala1377Val
missense
Exon 28 of 52NP_000543.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VWF
ENST00000261405.10
TSL:1 MANE Select
c.4130C>Tp.Ala1377Val
missense
Exon 28 of 52ENSP00000261405.5
VWF
ENST00000538635.5
TSL:4
n.421-25354C>T
intron
N/A
VWF
ENST00000539641.1
TSL:3
n.*240C>T
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.000598
AC:
91
AN:
152122
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000211
AC:
53
AN:
250788
AF XY:
0.000184
show subpopulations
Gnomad AFR exome
AF:
0.00267
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000718
AC:
105
AN:
1461650
Hom.:
0
Cov.:
38
AF XY:
0.0000605
AC XY:
44
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.00239
AC:
80
AN:
33472
American (AMR)
AF:
0.000246
AC:
11
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5760
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111840
Other (OTH)
AF:
0.000182
AC:
11
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000598
AC:
91
AN:
152240
Hom.:
0
Cov.:
32
AF XY:
0.000497
AC XY:
37
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.00217
AC:
90
AN:
41562
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000988
Hom.:
0
Bravo
AF:
0.000691
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000181
AC:
22

ClinVar

ClinVar submissions as Germline

Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
not provided (3)
-
2
-
not specified (2)
-
1
-
Hereditary von Willebrand disease (1)
-
1
-
von Willebrand disease type 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.094
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.48
T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.83
D
MetaRNN
Benign
0.079
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.8
H
PhyloP100
9.2
PrimateAI
Uncertain
0.48
T
PROVEAN
Benign
-1.9
N
REVEL
Pathogenic
0.81
Sift
Uncertain
0.0020
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.64
MVP
0.96
MPC
0.84
ClinPred
0.25
T
GERP RS
4.1
Varity_R
0.64
gMVP
0.82
Mutation Taster
=25/75
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141211612; hg19: chr12-6128454; API